GH Research PLC (GHRS)
11.25
-1.13
(-9.13%)
USD |
NASDAQ |
May 02, 16:00
11.25
0.00 (0.00%)
After-Hours: 20:00
GH Research Free Cash Flow (Quarterly): -8.109M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.109M |
| September 30, 2023 | -10.35M |
| June 30, 2023 | -8.072M |
| March 31, 2023 | -6.907M |
| December 31, 2022 | -6.885M |
| September 30, 2022 | -8.06M |
| June 30, 2022 | -5.31M |
| March 31, 2022 | -6.011M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.777M |
| September 30, 2021 | -9.263M |
| June 30, 2021 | -1.239M |
| March 31, 2021 | -1.108M |
| December 31, 2020 | -0.149M |
| September 30, 2020 | -0.077M |
| June 30, 2020 | -0.002M |
| March 31, 2020 | -0.102M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-10.35M
Minimum
Sep 2023
-0.002M
Maximum
Jun 2020
-4.714M
Average
-5.660M
Median
Free Cash Flow (Quarterly) Benchmarks
| Amarin Corp PLC | -1.154M |
| Jazz Pharmaceuticals PLC | 139.24M |
| Prothena Corp PLC | -52.59M |
| Iterum Therapeutics PLC | -12.84M |
| Mural Oncology PLC | -- |